Semisynthesis of Selenoauraptene.

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Selenium compounds show promise as anticancer and antioxidant agents.
• Ebselen is an approved drug known for glutathione peroxidase mimicking effects.
• Limited research exists on semi-synthetic selenium compounds resembling natural products.

Purpose of the Study:

• To synthesize the first selenium-phenylpropanoid, selenoauraptene.
• To develop a method for creating selenium analogs of oxyprenylated natural metabolites.

Main Methods:

• Newman-Kwart rearrangement to form a selenocarbamate.
• Hydrolysis to diumbelliferyl diselenide.
• Conversion to the Se-geranyl derivative.

Main Results:

• Successful synthesis of selenoauraptene with a 28.5% overall yield.
• The synthesized selenoauraptene exhibited superior in vitro antioxidant and radical scavenger activity compared to auraptene.
• Demonstrated an easy-to-handle method for synthesizing diverse seleno-analogues.

Conclusions:

• Developed a novel synthetic route for selenium-containing natural product analogs.
• Selenoauraptene shows enhanced biological activity, suggesting therapeutic potential.
• The described method facilitates the exploration of a wide range of selenium-based bioactive compounds.